Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof
US8222209B2 · kind B2 · utility
11Cited by
111References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2011 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | Jan 25, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are modified growth hormone polypeptides, nucleic acid molecules encoding modified growth hormone polypeptides and methods of generating modified growth hormone polypeptides. Also provided are methods of treatment using modified growth hormone polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.